Caris Life Sciences, Inc. (CAI)
26.06
+1.72
(+7.07%)
USD |
NASDAQ |
Sep 14, 16:00
26.06
0.00 (0.00%)
After-Hours: 18:12
Caris Life Sciences Enterprise Value : 6.537B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 6.537B |
| September 10, 2026 | 6.453B |
| September 09, 2026 | 6.450B |
| September 08, 2026 | 6.673B |
| September 04, 2026 | 6.744B |
| September 03, 2026 | 6.814B |
| September 02, 2026 | 6.667B |
| September 01, 2026 | 6.662B |
| August 31, 2026 | 6.862B |
| August 28, 2026 | 6.902B |
| August 27, 2026 | 7.114B |
| August 26, 2026 | 7.238B |
| August 25, 2026 | 7.574B |
| August 24, 2026 | 7.043B |
| August 21, 2026 | 7.083B |
| August 20, 2026 | 6.605B |
| August 19, 2026 | 6.091B |
| August 18, 2026 | 5.585B |
| August 17, 2026 | 5.772B |
| August 14, 2026 | 5.820B |
| August 13, 2026 | 5.927B |
| August 12, 2026 | 5.950B |
| August 11, 2026 | 6.198B |
| August 10, 2026 | 6.272B |
| August 07, 2026 | 6.085B |
| Date | Value |
|---|---|
| August 06, 2026 | 5.311B |
| August 05, 2026 | 4.308B |
| August 04, 2026 | 4.209B |
| August 03, 2026 | 4.271B |
| July 31, 2026 | 4.087B |
| July 30, 2026 | 4.206B |
| July 29, 2026 | 4.065B |
| July 28, 2026 | 4.065B |
| July 27, 2026 | 4.076B |
| July 24, 2026 | 4.045B |
| July 23, 2026 | 4.082B |
| July 22, 2026 | 4.005B |
| July 21, 2026 | 4.104B |
| July 20, 2026 | 4.056B |
| July 17, 2026 | 4.319B |
| July 16, 2026 | 4.316B |
| July 15, 2026 | 4.593B |
| July 14, 2026 | 4.449B |
| July 13, 2026 | 4.480B |
| July 10, 2026 | 4.460B |
| July 09, 2026 | 4.709B |
| July 08, 2026 | 4.554B |
| July 07, 2026 | 4.596B |
| July 06, 2026 | 4.692B |
| July 02, 2026 | 4.831B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CareDx, Inc. | 2.233B |
| Myriad Genetics, Inc. | 422.25M |
| BioRestorative Therapies, Inc. | -0.1562M |
| Natera, Inc. | 46.39B |
| Exagen, Inc. | 173.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.637M |
| Revenue (Quarterly) | 263.71M |
| Total Expenses (Quarterly) | 264.35M |
| EPS Diluted (Quarterly) | -0.0022 |
| Gross Profit Margin (Quarterly) | 68.10% |
| Profit Margin (Quarterly) | -0.24% |
| Earnings Yield | 1.43% |
| Operating Earnings Yield | 2.08% |
| Normalized Earnings Yield | 1.706 |